Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 1792-1800

  Ogilvy, Sarah ^a,c   Louis Dit Sully, Christine ^b,d   Cooper, Joanne ^a   Cassady, Robin L ^a   Alexander, Denis R ^a   Holmes, Nick ^b,d  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD45RB ANTIGEN; CD45RO ANTIGEN; ISOENZYME; ISOPROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; GENE FUNCTION; GENETIC COMPLEMENTATION; HEMATOPOIETIC CELL; HETEROZYGOTE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TECHNIQUE; THYMOCYTE; TISSUE SPECIFICITY; TRANSGENE; TRANSGENIC MOUSE;

EID: 0043092256     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.1792     Document Type: Article

References (41)

1. Thomas, M. L. 1989. The leukocyte common antigen family. Annu. Rev. Immunol. 7:339.
2. Stone, J. D., L. A. Conroy, K. F. Byth, R. A. Hederer, S. Howlett, Y. Takemoto, N. Holmes, and D. R. Alexander. 1997. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-ζ and ZAP-70. J. Immunol. 158:5773.
3. Cyster, J. G., J. I. Healy, K. Kishihara, T. W. Mak, M. L. Thomas, and C. C. Goodnow. 1996. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381:325.
4. Alexander, D. R. 2000. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin. Immunol. 12:349.
5. + thymocytes, and in B-cell maturation. J. Exp. Med. 183:1707.
6. Kishihara, K., J. Penninger, V. A. Wallace, T. M. Kundig, K. Kawai, D. Wakeham, E. Timms, K. Pfeffer, P. Ohashi, M. L. Thomas, et al. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon 6 protein tyrosine phosphatase deficient mice. Cell 74:143.
7. Mee, P. J., M. Turner, M. A. Basson, P. S. Costello, R. Zamoyska, and V. L. J. Tybulewicz. 1999. Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice. Eur. J. Immunol. 29:2923.
8. Roach, T., S. Slater, M. Koval, L. White, E. D. Cahir-McFarland, M. Okumura, M. Thomas, and E. Brown. 1997. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr. Biol. 7:408.
9. Tan, J., T. Town, and M. Mullan. 2000. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J. Biol. Chem. 275:372.
10. Irie-Sasaki, J., T. Sasaki, W. Matsumoto, A. Opavsky, M. Cheng, G. Welstead, E. Griffiths, C. Krawczyk, C. D. Richardson, K. Aitken, et al. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409:349.
11. Trowbridge, I. S., and M. L. Thomas. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85.
12. Leitenberg, D., Y. Boutin, D. D. Lu, and K. Bottomly. 1999. Biochemical association of CD45 with the T cell receptor complex: regulation by CD45 isoform and during T cell activation. Immunity. 10:701.
13. lck tyrosine kinase in T cell antigen receptor signal transduction. J. Biol. Chem. 277:1912.
14. Xu, Z., and A. Weiss. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:764.
15. Okumura, M., R. J. Matthews, B. Robb, G. W. Litman, P. Bork, and M. L. Thomas. 1996. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J. Immunol. 157:1569.
16. Barritt, L. C., and J. B. Turpen. 1995. Characterization of lineage restricted forms of a Xenopus CD45 homologue. Dev. Comp. Immunol. 19:525.
17. Nguyen, J. T., D. P. Evans, M. Galvan, K. E. Pace, D. Leitenberg, T. N. Bui, and L. G. Baum. 2001. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J. Immunol. 167:5697.
18. Martínez-Pomares, L., P. R. Crocker, R. Da Silva, N. Holmes, C. Colominas, P. Rudd, R. Dwek, and S. Gordon. 1999. Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor. J. Biol. Chem. 274:35211.
19. Van der Merwe, P. A., P. R. Crocker, M. Vinson, A. N. Barclay, R. Schauer, and S. Kelm. 1996. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J. Biol. Chem. 271:9273.
20. Leitenberg, D., T. J. Novak, D. Farber, B. R. Smith, and K. Bottomly. 1996. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 183:249.
21. Bilwes, A. M., J. den Hertog, T. Hunter, and J. P. Noel. 1996. Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization. Nature 382:555.
22. Majeti, R., A. M. Bilwes, J. P. Noel, T. Hunter, and A. Weiss. 1998. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279:88.
23. Ogilvy, S., A. G. Elefanty, J. Visvader, M. L. Bath, A. W. Harris, and J. M. Adams. 1998. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood 91:419.
24. Ogilvy, S., D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams. 1999. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. USA 96:14943.
25. Ogilvy, S., D. Metcalf, D. Gibson, M. L. Bath, A. W. Harris, and J. M. Adams. 1999. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood 94:1855.
26. Saga, Y., J. S. Tung, F. W. Shen, and E. A. Boyse. 1986. Sequences of Ly-5 cDNA: isoform-related diversity of Ly-5 mRNA. Proc. Natl. Acad. Sci. USA 83:6940.
27. - triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150:4244.
28. von Boehmer, H., and H. J. Fehling. 1997. Structure and function of the pre-T cell receptor. Annu. Rev. Immunol. 15:432.
29. lck. Eur. J. Immunol. 29:2376.
30. Su, T. T., and D. J. Rawlings. 2002. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168:2101.
31. Festenstein, R., M. Tolaini, P. Corbella, C. Mamalaki, J. Parrington, M. Fox, A. Miliou, M. Jones, and D. Kioussis. 1996. Locus control region function and heterochromatin-induced position effect variegation. Science 27:1123.
32. Kozieradzki, I., T. Kundig, K. Kishihara, C. J. Ong, D. Chiu, V. A. Wallace, K. Kawai, E. Timms, J. Ionescu, P. Ohashi, et al. 1997. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45. J. Immunol. 158:3.130.
33. Hatheock, K. S., G. Laszlo, H. B. Dickler, S. O. Sharrow, P. Johnson, I. S. Trowbridge, and R. J. Hodes. 1992. Expression of variable exon A-specific, B-specific and C-specific CD45 determinants on peripheral and thymic T cell populations. J. Immunol. 148:19.
34. Kong, Y. Y., K. Kishihara, H. Sumichika, T. Nakamura, M. Kaneko, and K. Nomoto. 1995. Differential requirements of CD45 for lymphocyte development and function. Eur. J. Immunol. 25:3431.
35. Petro, J. B., R. M. Gerstein, J. Lowe, R. S. Carter, N. Shinners, and W. N. Khan. 2002. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 277:48009.
36. Doody, G. M., S. E. Bell, E. Vigorito, E. Clayton, S. McAdam, R. Tooze, C. Fernandez, I. J. Lee, and M. Turner. 2001. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat. Immunol. 2:542.
37. Wang, D., J. Feng, R. Wen, J.-C. Marine, M. Y. Sangster, E. Parganas, A. Hoffmeyer, C. W. Jackson, J. L. Cleveland, P. J. Murray, and J. M. Ihle. 2000. Phospholipase Cy2 is essential in the functions of B cell and several Fc receptors. Immunity 13:25.
38. Fruhman, D. A., A. B. Satterthwaite, and O. N. Witte. 2000. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13:1.
39. Meade, J., C. Fernandez, and M. Turner. 2002. The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by over-expression of Bcl-2. Eur. J. Immunol. 32:1029.
40. Hathcock, K. S., H. Hirano, S. Murakami, and R. J. Hodes. 1992. CD45 expression by B cells: expression of different CD45 isoforms by subpopulations of activated B cells. J. Immunol. 149:2286.
41. Virts, E. L., O. Diago, and W. C. Raschke. 2003. A CD45 minigene restores regulated isoform expression and immune function in CD45 deficient mice: therapeutic implications for human CD45-null severe combined immunodeficiency. Blood 101:849.